
FDA Advisory Committee Unanimously Recommends Moderna's mRNA Flu Vaccine for Adults 50+
The FDA's vaccine advisory committee unanimously recommended Moderna's mRNA flu vaccine, mFlusiva, for adults 50 and over. This marks a significant step, potentially being the first vaccine approved under the second Trump administration despite past vaccine criticism from President Trump and HHS Secretary Robert F. Kennedy Jr.












